FAIRFIELD, N.J., Jan. 23, 2017 /PRNewswire-USNewswire/
-- The Healthcare Businesswomen's Association (HBA)
announced that its 2017 Woman of the Year is Bahija
Jallal, PhD, executive vice president, AstraZeneca, and head of
MedImmune. MedImmune is the global biologics research and
development arm of AstraZeneca.
"The Healthcare Businesswomen's Association is extremely proud
to honor Bahija Jallal as our 2017
Woman of the Year," said HBA CEO Laurie
Cooke. "Bahija brings her visionary leadership, sharp
intellect, and empowering presence to her organization and
challenges individuals to think bolder and dream bigger. Bahija's
commitment to mentoring young aspiring women, as well as launching
MedImmune's annual Women's Summit, exemplifies her dedication to
achieving gender parity for healthcare businesswomen."
Pascal Soriot, chief executive officer, AstraZeneca, said,
"Every day, Bahija is an inspiration to her staff, the employees of
MedImmune and AstraZeneca, countless scientists, business
colleagues outside of the company and the hundreds of women and men
across the globe who have had an opportunity to work with her in
some capacity. She inspires me as well and I am proud of all the
work she has done on behalf of patients."
Bahija will be honored at the HBA's 28th annual Woman of
the Year (WOTY) event on Thursday, 11 May, at the New York Hilton
Midtown. The WOTY event, which draws upward of
2,500 women and men from throughout the healthcare industry,
showcases the HBA's core purpose of furthering the advancement and
impact of women in the business of healthcare. Awards for Honorable
Mentor, STAR (Strategic Transformation Achievement Recognition) and
a group of some 100 Rising Stars and Luminaries, noted
for their accomplishments and contributions to the healthcare
industry, also will be presented at the WOTY event.
"I am humbled to receive this recognition, and to join the
distinguished list of HBA Woman of the Year recipients who have
come before me, working so tirelessly to improve patient lives,"
said Bahija. "I am proud to say that at MedImmune, about 50 percent
of our employees are female and our leadership team is equally
diverse. As the HBA Woman of the Year, it is a privilege for me to
represent not only these talented female innovators, but also so
many amazing women in the healthcare industry."
As executive vice president, AstraZeneca and head of MedImmune,
Bahija is responsible for biologics research, development and
clinical activities.
Bahija joined MedImmune as vice-president, translational
sciences in 2006 and became head of MedImmune in 2013. She has
guided MedImmune through an unprecedented expansion of its
pipeline; in fact, in 2007 MedImmune accounted for five percent of
the overall AstraZeneca pipeline, and today it represents
approximately 50 percent. The company now has more than 130
biologics in R&D and 40 products in clinical development.
Bahija has authored more than 70 peer-reviewed publications and
holds more than 15 patents. She is a member of the American
Association for Cancer Research, the American Association of the
Advancement of Science, and is president of the board of directors
of the Association of Women in Science. Bahija also serves on the
board of trustees of the Johns Hopkins
University in Baltimore,
Maryland.
Bahija received a master's degree in biology from the Universite
de Paris VII in France, and her
doctorate in physiology from the University of Pierre &
Marie Curie in Paris. She conducted her postdoctoral research
at the Max-Planck Institute of Biochemistry in Martinsried,
Germany.
About the HBA
The Healthcare Businesswomen's
Association (HBA) is a global nonprofit organization comprised of
individuals and companies from across the healthcare industry
committed to achieving gender parity in leadership positions,
facilitating career and business connections and providing
effective practices that enable organizations to realize the full
potential of their female talent.
The HBA accomplishes its mission through strong business
networks, education, research, advocacy and recognition for
individuals and companies.
The HBA has nearly 120 Corporate Partners and 8,000 members
served by more than 20 chapters and affiliates across the US and
Europe.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/bahija-jallal-of-medimmune-named-2017-woman-of-the-year-by-the-healthcare-businesswomens-association-300394759.html
SOURCE Healthcare Businesswomen's Association